EV Biologics, Inc. (YECO)

Market Cap	4.09K -99.6%
Revenue (ttm)	9.47M -70.5%
Net Income	-551.58K
EPS	-0.23
Shares Out	10.23M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,735
Open	0.0004
Previous Close	0.0002
Day's Range	0.0004 - 0.0004
52-Week Range	0.0002 - 0.1056
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About EV Biologics

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Employees: 284
• Stock Exchange: OTCMKTS
• Ticker Symbol: YECO

Financial Performance

In 2017, EV Biologics's revenue was $9.47 million, a decrease of -0.34% compared to the previous year's $9.51 million. Losses were -$551,581, -92.58% less than in 2017.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 21, 2026

Data Sources Report a data error